Viewray to Expand to Denver, Adding 274 Jobs
By: Colorado BioScience Association Date: 07/16/2019
Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...
Learn MoreWeekly Policy Update: Trump Administration Pulls Rebate Rule
By: Colorado BioScience Association Date: 07/15/2019
Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...
Learn MoreWeekly Policy Update: Drug Pricing Bills Pass Key Senate Committees
By: Colorado BioScience Association Date: 07/08/2019
Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....
Learn MoreWeekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap
By: Colorado BioScience Association Date: 06/20/2019
The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...
Learn MoreNew State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics
By: Colorado BioScience Association Date: 06/18/2019
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...
Learn MorePfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion
By: Colorado BioScience Association Date: 06/17/2019
Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...
Learn MoreWeekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax
By: Colorado BioScience Association Date: 06/14/2019
Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...
Learn MoreCutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals
By: Colorado BioScience Association Date: 06/13/2019
WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...
Learn MoreWeekly Policy Update: CBSA Attends the 2019 BIO International Convention
By: Colorado BioScience Association Date: 06/10/2019
Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...
Learn MoreColorado BioScience Association Celebrates State’s Collaborative Nature
By: Colorado BioScience Association Date: 06/03/2019
New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals DENVER – Colorado BioScience Association (CBSA) today launched the new issue of its annual magazine, BioSc...
Learn More